Douglas Naversen, MD
Dermatology · Medford, ORNPI 1568405496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,276 of the $3,688 with a category attached, or 88.8%. 19 manufacturers reported payments, led by AbbVie at 26.9% of the total.
Across 165 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$993
- Johnson & Johnson$822
- Lilly USA, LLC$569
- Galderma Laboratories, L.p.$231
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$195
- Regeneron Healthcare Solutions, Inc.$180
- plus $699 from 13 others
What the payments were for
- Food & beverage$3,27689%
- Education$41211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $993 |
| Johnson & Johnson | 41 | $822 |
| Lilly USA, LLC | 24 | $569 |
| Galderma Laboratories, L.p. | 8 | $231 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $195 |
| Regeneron Healthcare Solutions, Inc. | 6 | $180 |
| Janssen Scientific Affairs, LLC | 1 | $93 |
| Sanofi | 4 | $89 |
| Novartis | 4 | $76 |
| Pfizer | 3 | $75 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| UCB, Inc. | 3 | $66 |
| LEO Pharma Inc. | 1 | $50 |
| Boehringer Ingelheim | 1 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Dermavant Sciences, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $17 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,688 in reported general payments places this provider in the 65th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $81,989 |
| Dupixent SyringeDupilumab | 15 | $69,076 |
| OtezlaApremilast | 14 | $67,842 |
| Dupixent PenDupilumab | 12 | $53,039 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 78 | $5,434 |
| Clobetasol Propionate | 123 | $4,612 |
| Mupirocin | 284 | $2,147 |
| Doxycycline Hyclate | 127 | $2,003 |
| Triamcinolone Acetonide | 198 | $1,693 |
| Metronidazole | 30 | $1,593 |
| Fluorouracil | 15 | $1,159 |
| Ketoconazole | 80 | $1,117 |
| Clindamycin Phosphate | 48 | $1,114 |
| Fluocinonide | 32 | $1,052 |
| Terbinafine Hcl | 18 | $682 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Medford
- Laurel GeraghtyMedford$6K
- Thomas EvansMedford$4K
- Natasha ZacherMedford$4K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.